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Therapeutic hypothermia (TH) with intra-corporeal temperature monitoring commenced within 6 h of birth is standard 
of care for babies with suspected hypoxic-ischaemic encephalopathy.1 While the 2010 British Association of Perinatal 
Medicine position statement advised active or passive cooling to provide TH,2 subsequent data from transport services 
showed that active cooling with intra-corporeal temperature monitoring minimised stabilisation and transfer times and 
achieved target temperature in 100% of cases compared to passive cooling.3 Routine cerebral function monitoring 
(CFM) can aid the early diagnosis and treatment of encephalopathy and seizures. Our previous UK-wide survey in 2009 
highlighted that overall <50% of units across UK had CFM and <30% had active cooling equipment.4 A decade on, we 
have repeated a UK-wide telephone survey to understand the current situation.  
 
Between December 2019 and July 2020, we surveyed all UK neonatal units through a senior nurse, unit manager or 
consultant. We obtained responses from all 189 (100%) units. Table 1 summarises the results by UK neonatal network 
and level of units within each network. Of neonatal intensive care units (NICUs), currently only 2/57 (4%) units do not 
have access to either CFM or active cooling equipment. However, 32/57 (56%) NICUs do not have out-of-hours access 
to formal EEG (electroencephalogram) services. Of local neonatal units (LNUs), currently <50% provide active cooling 
although more than two thirds have CFM available. Figure 1 illustrates variations across the UK neonatal networks in 
terms of availability of CFM and active cooling equipment. Only two networks had 100% availability of CFM in all 
their units, and one network had active cooling available in >90% of its units. 
 
In summary, despite an increase in CFM use and active cooling since 2009, there are significant variations 
geographically based on the network policies. Early aEEG was a sufficiently sensitive screening tool used in the main 
hypothermia trials for selection of babies for TH. It also reduces overtreatment of seizures which impacts ongoing 
neurological assessment. Nevertheless, use of CFM requires training and maintenance of skills along with expertise for 
correct interpretation. Network NICUs and transport teams could help with interpretation via remote electronic review 
of aEEG traces. Although all transport teams and almost all NICUs use servo-controlled active cooling, earlier 
achievement of target temperature at LNUs and special care baby units is possible for eligible encephalopathic babies 
by using active cooling equipment, and this would potentially improve their outcomes.5 The introduction of modern 
servo-controlled active cooling equipment and non-needle CFM devices and neonatal EEG sensor caps can minimise 
staff training needs.  
 
While aEEG and active cooling are both considered gold standard for units providing TH, the current state reflects the 
complexity of translating advances in monitoring and treatment into practice. With the sharing of best practices amongst 
networks, increased use of telemedicine and modern equipment, earlier initiation of TH reliably in all local hospitals 
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using active cooling with routine neurophysiological monitoring is feasible. This would permit a more consistent 
approach to the management of neonatal encephalopathy for all babies irrespective of their place of birth.   
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Table 1: Regional availability of CFM and active cooling facilities based on neonatal networks 
 
SCBU - Special Care Baby Unit; LNU - Local Neonatal Unit; NICU - Neonatal Intensive Care Unit 
 
 
 
 
 
 
 
 
Figure 1: Geographical variations in availability of cerebral function monitoring and active cooling facilities 
Neonatal Network 
Percentage of CFM 
availability by level of 
care 
SCBU/LNU/NICU (Total) 
% 
Percentage of active 
cooling availability by 
level of care 
SCBU/LNU/NICU (Total) 
% 
Total number of 
neonatal units by 
level of care 
SCBU/LNU/NICU 
(Total) 
South West 100/100/100 (100%) 0/100/100 (75%) 3/6/3 (12) 
Wales 100/100/100 (100%) 0/80/100 (64%) 3/5/3(11) 
East of England 50/100/100 (88%) 50/20/100 (29%) 4/10/3 (17) 
East Midlands 40/100/100 (79%) 0/40/100 (43%) 5/5/4 (14) 
London 25/85/89 (77%) 0/46/89 (54%) 4/13/9 (26) 
West Midlands 0/80/100 (73%) 0/40/100 (55%) 2/5/4 (11) 
North West 50/58/100 (71%) 50/33/100 (57%) 2/12/7 (21) 
Scotland 0/50/100 (71%) 0/25/100 (64%) 2/4/8 (14) 
Kent Surrey & Sussex 17/100/100 (62%) 83/100/100 (92%) 6/3/4 (13) 
Northern Ireland 0/75/100 (57%) 0/100/100 (71%) 2/4/1 (7) 
Thames Valley & Wessex 0/56/100 (57%) 0/44/100 (50%) 2/9/3 (14) 
Yorkshire & Humber 0/40/80 (42%) 0/0/80 (21%) 4/10/5 (19) 
Northern 0/0/100 (30%) 0/0/100 (30%) 7/0/3 (10) 
Grand Total 133/189 (71%) 99/189 (52%) 189 
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